Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Amneal Pharmaceuticals Ltd. (NASDAQ: AMRX), Canada – FDA Inspections
Company
•Canada•Public company, NASDAQ: AMRX

Amneal Pharmaceuticals Ltd. (NASDAQ: AMRX), Canada – FDA Inspections

Inspection records and compliance data for Amneal Pharmaceuticals Ltd.. Access full analysis and detailed observations. Publicly traded as NASDAQ: AMRX.

Sign in to open in Dashboard
Company Profile

This profile covers Amneal Pharmaceuticals Ltd. based in Canada.

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)
  • Health Canada · 1 inspection · last August 14, 2012
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Patheon UK Ltd.
STD Pharmaceutical Products Limited
Abbott Logistics B.V.
Jazz Pharmaceuticals Canada Inc.
2311979 Ontario Inc.
Zydus Nycomed Healthcare Pvt. Ltd.
CTP Chem S.R.L.
Glycotope Biotechnology GmbH
Pfizer PGM
Agila Specialities Private Limited (Speciality Formulation Facility)
Company Information

Name

Amneal Pharmaceuticals Ltd.

Stock ticker

AMRX

Exchange

NASDAQ

Share price

$21.70

Market cap

$7.6B

Price as of

November 13, 2026

Address

Canada

Country

Canada

ID: 26e196c2-01e2-4257-8b10-a46215c22acb

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.